First AD

Second AD

News Network

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Atopic Dermatitis

INC-22-MDD0529 - /clinical/atopic-dermatitis

Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Long-term Use and Safety of JAK Inhibitors and Evaluating Efficacy Outcomes in Atopic Dermatitis

 Insights page is a resource for professional video interviews with leading clinical experts and investigators across all specialties of medicine.

Insights

Andrew Blauvelt, MD, provides an overview of the significance of JAK/Stat pathway inhibition in targeting the pathophysiology of atopic dermatology (AD).

Pathophysiology of AD Treatments

Standard of Care in AD

Clinical Outcomes in AD Clinical Trials

EASI Scores in AD Treatment

NRS in AD Treatment

AD: Efficacy Outcomes

RAD 2023 AD Trial: Meta-Analysis Data

AD Clinical Approach: Switching Therapies

Topical and Systemic Treatments for AD

Treatment Selection in AD 

JAK Inhibitor Safety 

AD Treatment: Upadacitinib 

Switching Therapies in AD